- Home
- SIDU vs NLSP Comparison
SIDU vs NLSP Comparison
Compare SIDU & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIDU
- NLSP
- Stock Information
- Founded
- SIDU 2012
- NLSP 2015
- Country
- SIDU United States
- NLSP Switzerland
- Employees
- SIDU N/A
- NLSP N/A
- Industry
- SIDU Telecommunications Equipment
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- SIDU Telecommunications
- NLSP Health Care
- Exchange
- SIDU Nasdaq
- NLSP Nasdaq
- Market Cap
- SIDU 10.3M
- NLSP 243.8M
- IPO Year
- SIDU 2021
- NLSP 2021
- Fundamental
- Price
- SIDU $2.47
- NLSP $4.96
- Analyst Decision
- SIDU Strong Buy
- NLSP
- Analyst Count
- SIDU 1
- NLSP 0
- Target Price
- SIDU $10.00
- NLSP N/A
- AVG Volume (30 Days)
- SIDU 363.4K
- NLSP 34.6K
- Earning Date
- SIDU 11-12-2024
- NLSP 11-01-2024
- Dividend Yield
- SIDU N/A
- NLSP N/A
- EPS Growth
- SIDU N/A
- NLSP N/A
- EPS
- SIDU N/A
- NLSP N/A
- Revenue
- SIDU $4,306,474.00
- NLSP N/A
- Revenue This Year
- SIDU $36.85
- NLSP N/A
- Revenue Next Year
- SIDU $40.00
- NLSP N/A
- P/E Ratio
- SIDU N/A
- NLSP N/A
- Revenue Growth
- SIDU N/A
- NLSP N/A
- 52 Week Low
- SIDU $2.02
- NLSP $4.08
- 52 Week High
- SIDU $18.85
- NLSP $29.68
- Technical
- Relative Strength Index (RSI)
- SIDU 44.54
- NLSP 46.37
- Support Level
- SIDU $2.14
- NLSP $4.52
- Resistance Level
- SIDU $2.53
- NLSP $5.64
- Average True Range (ATR)
- SIDU 0.20
- NLSP 0.48
- MACD
- SIDU -0.01
- NLSP 0.07
- Stochastic Oscillator
- SIDU 42.40
- NLSP 55.44
About SIDU Sidus Space Inc.
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.